BRAHMS KYPTOR PCT
Device
Brahms GmbH
Total Payments
$500,000
Transactions
2
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $500,000 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $500,000 | 2 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| PROcalcitonin impact on antibiotic reduction, adverSe events and AVoidable healthcarE costs (ProSAVE) | Brahms GmbH | $500,000 | 0 |
Top Doctors Receiving Payments for BRAHMS KYPTOR PCT
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $500,000 | 2 |
Ad
Manufacturing Companies
- Brahms GmbH $500,000
Product Information
- Type Device
- Total Payments $500,000
- Total Doctors 0
- Transactions 2
About BRAHMS KYPTOR PCT
BRAHMS KYPTOR PCT is a device associated with $500,000 in payments to 0 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is Brahms GmbH.
Payment data is available from 2021 to 2021. In 2021, $500,000 was paid across 2 transactions to 0 doctors.
The most common payment nature for BRAHMS KYPTOR PCT is "Unspecified" ($500,000, 100.0% of total).
BRAHMS KYPTOR PCT is associated with 1 research study, including "PROcalcitonin impact on antibiotic reduction, adverSe events and AVoidable healthcarE costs (ProSAVE)" ($500,000).